FDA
-
-
-
-
-
-
-
Hemostemix files FDA pre-submission for multi-indication stem cell trial
-
-
-
-
-
-
-
Hemostemix's Pitch to Wall Street: ACP-01 Vascular Dementia Trial will Generate $5,365,000, Capture Data, as a Phase 1 Clinical Trial
-
-
-
-
-
-
-
Hemostemix Provides Highlights of 2018 Accomplishments
-
-
-
-
-
-
-
Hemostemix Announces Two New Strategic Trial Sites in Texas
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

